FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1348101000168102: Bydureon (exenatide 2 mg) modified release injection [1 x 2 mg chamber] (&) (inert substance) diluent [1 chamber], 1 dual chamber pen device (containered trade product pack)


Status: current, Defined. Date: 31-Jul 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3429401000168115 Bydureon (exenatide 2 mg) modified release injection [1 x 2 mg chamber] (&) (inert substance) diluent [1 chamber], 1 dual chamber pen device (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3429411000168117 Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device Is a Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device true Inferred relationship Some
Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device Is a containered trade product pack true Inferred relationship Some
Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device has TPUU Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber true Inferred relationship Some 2
Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device has TPUU Bydureon (inert substance) diluent, chamber true Inferred relationship Some 1
Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device has container type dual chamber pen device true Inferred relationship Some
Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device has TP Bydureon true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 4 dual chamber pen devices has subpack True Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device Inferred relationship Some 1

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start